Marshall Wace Asia’s Cigna CI Stock Holding History

Marshall Wace Asia’s Portfolio CI Stock Details CI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-13,370	Closed	-$2.5M	–	103
2017 Q3	$2.5M	Buy	+13,370	New	+$2.38M	0.12%	58

Other funds holding CI

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Marshall Wace Asia's CI Position: Q4 2017 in Review

Marshall Wace Asia sold out of Cigna (CI) in Q4 2017, closing a stake of 13,370 shares — an estimated $2.5M sold.

Marshall Wace Asia first reported a position in CI in Q3 2017 and held it in 1 quarter. The position peaked at $2.5M in Q3 2017. 865 funds tracked by Wall St. Rank hold CI as of Q4 2017.

Marshall Wace Asia reported no remaining Cigna position as of Q4 2017 after selling out during the quarter.
Marshall Wace Asia sold 13,370 Cigna shares in Q4 2017, an estimated $2.5M.
Marshall Wace Asia first reported a position in Cigna in Q3 2017 and held it in 1 quarter.
Marshall Wace Asia's Cigna position peaked at $2.5M in Q3 2017.
865 funds tracked by Wall St. Rank held Cigna as of Q4 2017.

Based on Marshall Wace Asia's 13F filing for Q4 2017, filed 14 Feb 2018.